Onkos Surgical, a devicemaker specializing in musculoskeletal oncology and complex orthopedics, on June 13 entered into a definitive agreement to acquire Stryker's Juvenile tumor system.
The Juvenile tumor system enables limb stabilization and growth in pediatric patients affected by bone cancers, severe arthropathy, trauma, revisions, oncology and malignant diseases.
The device allows for noninvasive lengthening of the implant post-surgery over time, according to Stryker. Its design eliminates the need for multiple limb-lengthening surgeries, anesthesia or sedation, which helps reduce the risk of complications and the cost of limb reconstruction.
"Our 'why' has always driven us to specifically address the many clinical challenges the [musculoskeletal oncology] community of surgeons and patients face on a daily basis," Patrick Treacy, co-founder and CEO of Onkos Surgical, said in a company news release. "Pediatric cancer surgery and limb lengthening are complex and challenging procedures, and the JTS extendible prosthesis is a solution in service of this mission."